SGH
CLVS

Schonfeld Group Holdings’s Clovis Oncology, Inc. CLVS Stock Holding History

Schonfeld Group Holdings’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-4,300
Closed -$261K – 412
2013
Q3 		$261K Buy
+4,300
New +$305K 0.53% 70

Other funds holding CLVS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCA
SAC Capital Advisors Stamford, Connecticut $19.3B AUM 31.93% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CPCM
Clifton Park Capital Management Wilmington, Delaware $881M AUM 5.59% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Schonfeld Group Holdings's CLVS Position: Q4 2013 in Review

Schonfeld Group Holdings sold out of Clovis Oncology, Inc. (CLVS) in Q4 2013, closing a stake of 4,300 shares — an estimated $261K sold.

Schonfeld Group Holdings first reported a position in CLVS in Q3 2013 and held it in 1 quarter. The position peaked at $261K in Q3 2013. 112 funds tracked by Wall St. Rank hold CLVS as of Q4 2013.

  • Schonfeld Group Holdings reported no remaining Clovis Oncology, Inc. position as of Q4 2013 after selling out during the quarter.
  • Schonfeld Group Holdings sold 4,300 Clovis Oncology, Inc. shares in Q4 2013, an estimated $261K.
  • Schonfeld Group Holdings first reported a position in Clovis Oncology, Inc. in Q3 2013 and held it in 1 quarter.
  • Schonfeld Group Holdings's Clovis Oncology, Inc. position peaked at $261K in Q3 2013.
  • 112 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2013.

Based on Schonfeld Group Holdings's 13F filing for Q4 2013, filed 14 Feb 2014.